Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8531308rdf:typepubmed:Citationlld:pubmed
pubmed-article:8531308lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8531308lifeskim:mentionsumls-concept:C0020557lld:lifeskim
pubmed-article:8531308lifeskim:mentionsumls-concept:C0360714lld:lifeskim
pubmed-article:8531308lifeskim:mentionsumls-concept:C0286651lld:lifeskim
pubmed-article:8531308lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:8531308pubmed:issue2lld:pubmed
pubmed-article:8531308pubmed:dateCreated1996-2-1lld:pubmed
pubmed-article:8531308pubmed:abstractTextTo assess the lipid-lowering effect of atorvastatin (a new 3-hydroxy-3-methylglutaryl coenzyme A [HMG-CoA] reductase inhibitor) on levels of serum triglycerides and other lipoprotein fractions in patients with primary hypertriglyceridemia, determine if atorvastatin causes a redistribution of triglycerides in various lipoprotein fractions, and assess its safety by reporting adverse events and clinical laboratory measurements.lld:pubmed
pubmed-article:8531308pubmed:languageenglld:pubmed
pubmed-article:8531308pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8531308pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8531308pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8531308pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8531308pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8531308pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8531308pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8531308pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8531308pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8531308pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8531308pubmed:statusMEDLINElld:pubmed
pubmed-article:8531308pubmed:monthJanlld:pubmed
pubmed-article:8531308pubmed:issn0098-7484lld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:WeissS RSRlld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:BrownW VWVlld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:DavignonJJlld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:BlackD MDMlld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:GoldsteinR...lld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:DavidsonM HMHlld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:MillerV TVTlld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:IsaacsohnJ...lld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:Bakker-Arkema...lld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:KeilsonL MLMlld:pubmed
pubmed-article:8531308pubmed:authorpubmed-author:ShurzinskeL...lld:pubmed
pubmed-article:8531308pubmed:issnTypePrintlld:pubmed
pubmed-article:8531308pubmed:day10lld:pubmed
pubmed-article:8531308pubmed:volume275lld:pubmed
pubmed-article:8531308pubmed:ownerNLMlld:pubmed
pubmed-article:8531308pubmed:authorsCompleteYlld:pubmed
pubmed-article:8531308pubmed:pagination128-33lld:pubmed
pubmed-article:8531308pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:meshHeadingpubmed-meshheading:8531308-...lld:pubmed
pubmed-article:8531308pubmed:year1996lld:pubmed
pubmed-article:8531308pubmed:articleTitleEfficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.lld:pubmed
pubmed-article:8531308pubmed:affiliationParke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, Mich 48105-1047, USA.lld:pubmed
pubmed-article:8531308pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8531308pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8531308pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8531308pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8531308lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8531308lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8531308lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8531308lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8531308lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8531308lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8531308lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8531308lld:pubmed